Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,959 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cunningham D, et al. N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025. N Engl J Med. 2004. PMID: 15269313 Clinical Trial.
A preliminary clinical study of gossypol in advanced human cancer.
Stein RC, Joseph AE, Matlin SA, Cunningham DC, Ford HT, Coombes RC. Stein RC, et al. Cancer Chemother Pharmacol. 1992;30(6):480-2. doi: 10.1007/BF00685601. Cancer Chemother Pharmacol. 1992. PMID: 1394805 Clinical Trial.
Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study.
Stein RC, Dowsett M, Cunningham DC, Davenport J, Ford HT, Gazet JC, von Angerer E, Coombes RC. Stein RC, et al. Br J Cancer. 1990 Mar;61(3):451-3. doi: 10.1038/bjc.1990.99. Br J Cancer. 1990. PMID: 2328214 Free PMC article.
Failure of conventional chemotherapy in aggressive lymphomas.
Cunningham D, Hepplestone A, Gilchrist NL, Dagg JH, Evans IL, Soukop M. Cunningham D, et al. Postgrad Med J. 1987 Jan;63(735):11-5. doi: 10.1136/pgmj.63.735.11. Postgrad Med J. 1987. PMID: 2444960 Free PMC article.
Cytotoxic drugs for gastric and colorectal cancer.
Cunningham D. Cunningham D. BMJ. 1989 Dec 16;299(6714):1479-80. doi: 10.1136/bmj.299.6714.1479. BMJ. 1989. PMID: 2514857 Free PMC article. Review. No abstract available.
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
Hill M, Norman A, Cunningham D, Findlay M, Watson M, Nicolson V, Webb A, Middleton G, Ahmed F, Hickish T, et al. Hill M, et al. J Clin Oncol. 1995 Sep;13(9):2317-23. doi: 10.1200/JCO.1995.13.9.2317. J Clin Oncol. 1995. PMID: 7666089 Clinical Trial.
PATIENTS AND METHODS: Patients who attended our unit with histologically confirmed advanced colorectal cancer were randomized to receive either PVI 5-FU 300 mg/m2/d via Hickman line, and IFN 5 MU subcutaneously three times weekly, or PVI 5-FU alone. ...
PATIENTS AND METHODS: Patients who attended our unit with histologically confirmed advanced colorectal cancer were randomized to receive eit …
Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.
Linch DC, Scarffe H, Proctor S, Chopra R, Taylor PR, Morgenstern G, Cunningham D, Burnett AK, Cawley JC, Franklin IM, et al. Linch DC, et al. Bone Marrow Transplant. 1993 Apr;11(4):307-11. Bone Marrow Transplant. 1993. PMID: 7683552 Clinical Trial.
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
Hill M, Norman A, Cunningham D, Findlay M, Nicolson V, Hill A, Iveson A, Evans C, Joffe J, Nicolson M, et al. Hill M, et al. J Clin Oncol. 1995 Jun;13(6):1297-302. doi: 10.1200/JCO.1995.13.6.1297. J Clin Oncol. 1995. PMID: 7751874 Clinical Trial.
PATIENTS AND METHODS: Patients with histologically confirmed advanced colorectal cancer were randomized to receive 5-FU 750 mg/m2/d by continuous infusion for 5 consecutive days followed by weekly bolus 5-FU 750 mg/m2 either with or without IFN 10 MU subcutaneously three t …
PATIENTS AND METHODS: Patients with histologically confirmed advanced colorectal cancer were randomized to receive 5-FU 750 mg/m2/d b …
1,959 results
Jump to page
Feedback